These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28062605)

  • 1. An Interview with Robert Califf.
    Landau M
    Clin Chem; 2017 Jan; 63(1):5-13. PubMed ID: 28062605
    [No Abstract]   [Full Text] [Related]  

  • 2. The Evolution of Federal Regulation of Human Drugs in the United States: An Historical Essay.
    Hutt PB
    Am J Law Med; 2018 May; 44(2-3):403-451. PubMed ID: 30106657
    [No Abstract]   [Full Text] [Related]  

  • 3. Learning about the safety of drugs--a half-century of evolution.
    Avorn J
    N Engl J Med; 2011 Dec; 365(23):2151-3. PubMed ID: 22150034
    [No Abstract]   [Full Text] [Related]  

  • 4. A brief history of FDA compounding oversight.
    Shulman ST
    Pediatr Ann; 2013 Jan; 42(1):2-3. PubMed ID: 23316818
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulating Homeopathic Products - A Century of Dilute Interest.
    Podolsky SH; Kesselheim AS
    N Engl J Med; 2016 Jan; 374(3):201-3. PubMed ID: 26789866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losing deference in the FDA's second century: judicial review, politics, and a diminished legacy of expertise.
    O'Reilly JT
    Cornell Law Rev; 2008 Jul; 93(5):939-80. PubMed ID: 18618965
    [No Abstract]   [Full Text] [Related]  

  • 7. Access before approval--a right to take experimental drugs?
    Okie S
    N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545
    [No Abstract]   [Full Text] [Related]  

  • 8. Invisible monuments and the costs of pharmaceutical regulation: twenty-five years of drug lag debate.
    Daemmrich A
    Pharm Hist; 2003; 45(1):3-17. PubMed ID: 12691078
    [No Abstract]   [Full Text] [Related]  

  • 9. Shifting terrain in the regulation of off-label promotion of pharmaceuticals.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2009 Apr; 360(15):1557-66. PubMed ID: 19357413
    [No Abstract]   [Full Text] [Related]  

  • 10. Shattuck lecture. Innovation, regulation, and the FDA.
    Hamburg MA
    N Engl J Med; 2010 Dec; 363(23):2228-32. PubMed ID: 21121835
    [No Abstract]   [Full Text] [Related]  

  • 11. Fifty Years of Expert Advice - Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study.
    Schwartz JL
    N Engl J Med; 2016 Nov; 375(21):2015-2017. PubMed ID: 27959733
    [No Abstract]   [Full Text] [Related]  

  • 12. The FDA clinical trial process: effectuating change in the regulatory framework governing clinical trials to account for the historical shift from "traditional" to "new" phase I trials.
    Aldes JL
    Health Matrix Clevel; 2008; 18(2):463-500. PubMed ID: 19739574
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA's Proposed Ban on Menthol Cigarettes.
    Wailoo K
    N Engl J Med; 2019 Mar; 380(11):995-997. PubMed ID: 30786182
    [No Abstract]   [Full Text] [Related]  

  • 14. The FDA Amendments Act of 2007 - Assessing Its Effects a Decade Later.
    Avorn J; Kesselheim A; Sarpatwari A
    N Engl J Med; 2018 Sep; 379(12):1097-1099. PubMed ID: 30231220
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory status of caffeine in the United States.
    Rosenfeld LS; Mihalov JJ; Carlson SJ; Mattia A
    Nutr Rev; 2014 Oct; 72 Suppl 1():23-33. PubMed ID: 25293541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals.
    Greene JA; Watkins ES
    N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749
    [No Abstract]   [Full Text] [Related]  

  • 17. The Atlanta Falcon and Tono-Bungay: dietary supplements as subprime drugs.
    Weissmann G
    FASEB J; 2009 May; 23(5):1279-82. PubMed ID: 19406845
    [No Abstract]   [Full Text] [Related]  

  • 18. There really is no controversy.
    Samuels A
    Eur J Clin Nutr; 2009 Aug; 63(8):1044. PubMed ID: 18545263
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulating compounding pharmacies after NECC.
    Outterson K
    N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA regulation of tobacco.
    Nitzkin JL
    N Engl J Med; 2008 Nov; 359(19):2070; author reply 2070-1. PubMed ID: 18987378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.